Literature DB >> 32604334

Outcomes and Disposition of Oncology Patients With Non-neutropenic Fever and Positive Blood Cultures.

Aditya Sharma1, Jitsuda Sitthi-Amorn1,2, Patrick Gavigan3, Joshua Wolf4,5, Asya Agulnik6, Alex Brenner7, Ying Li8, Liza-Marie Johnson2.   

Abstract

Children with cancer and non-neutropenic fever (NNF) episodes are often treated as outpatients if they appear well. However, a small subset have bloodstream infections (BSIs) and must return for further evaluation. These patients may be directly admitted to inpatient units, whereas others are first evaluated in outpatient settings before admission. The best practice for securing care for patients discovered to have outpatient bacteremia are unclear. To determine outcomes and compare time to antibiotics between the 2 disposition, we retrospectively reviewed all NNF initially treated as outpatients and later had positive blood cultures from 2012 to 2016. Of 845 NNF cases initially treated in outpatient settings, 48 episodes (n=43 patients) had BSIs. Of those, 77.1% (n=37) were re-evaluated as outpatients and admitted; 14.6% (n=7) were direct admissions. The median time to antibiotic did not significantly differ between outpatient re-evaluations (119 min) and direct admissions (191 min), P=0.11. One patient met sepsis criteria upon return and required intensive care unit admission for vasopressor support. No patient died within 1 week of the febrile episode. Most patients with NNF and BSIs initially discharged are stable upon return. Institutions should evaluate their patient flows to ensure that patients receive timely care.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32604334      PMCID: PMC7762736          DOI: 10.1097/MPH.0000000000001878

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.170


  24 in total

1.  Validation of a Pediatric Early Warning Score in Hospitalized Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.

Authors:  Asya Agulnik; Peter W Forbes; Nicole Stenquist; Carlos Rodriguez-Galindo; Monica Kleinman
Journal:  Pediatr Crit Care Med       Date:  2016-04       Impact factor: 3.624

2.  Approach to Non-Neutropenic Fever in Pediatric Oncology Patients-A Single Institution Study.

Authors:  Bilal Abou Ali; Nader Hirmas; Hani Tamim; Zeina Merabi; Rima Hanna-Wakim; Samar Muwakkit; Miguel Abboud; Hassan El Solh; Raya Saab
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

3.  The impact of the first notification of positive blood cultures on antibiotic therapy. A one-year survey.

Authors:  H C Schønheyder; T Højbjerg
Journal:  APMIS       Date:  1995-01       Impact factor: 3.205

4.  Why pediatric patients with cancer visit the emergency department: United States, 2006-2010.

Authors:  Emily L Mueller; Amber Sabbatini; Achamyeleh Gebremariam; Rajen Mody; Lillian Sung; Michelle L Macy
Journal:  Pediatr Blood Cancer       Date:  2014-10-24       Impact factor: 3.167

5.  The Surviving Sepsis Campaign Bundle: 2018 Update.

Authors:  Mitchell M Levy; Laura E Evans; Andrew Rhodes
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

6.  Detecting delayed microbiology results after hospital discharge: improving patient safety through an automated medical informatics tool.

Authors:  John W Wilson; William F Marshall; Lynn L Estes
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

7.  Outcomes of observation without empiric intravenous antibiotics in febrile, nonneutropenic pediatric oncology patients.

Authors:  Natalie Wu; William Muller; Elaine Morgan
Journal:  Pediatr Blood Cancer       Date:  2018-11-26       Impact factor: 3.167

8.  A comparison of ED and direct admission care of cancer patients with febrile neutropenia.

Authors:  Diwura K Owolabi; Richard Rowland; Lauren King; Rick Miller; Gajanan G Hegde; Jennifer Shang; John Lister; Arvind Venkat
Journal:  Am J Emerg Med       Date:  2015-04-23       Impact factor: 2.469

9.  Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.

Authors:  Adam J Esbenshade; M Cecilia Di Pentima; Zhiguo Zhao; Ayumi Shintani; Jennifer C Esbenshade; Monique E Simpson; Kathleen C Montgomery; Robert B Lindell; Haerin Lee; Ato Wallace; Kelly L Garcia; Karel G M Moons; Debra L Friedman
Journal:  Pediatr Blood Cancer       Date:  2014-10-18       Impact factor: 3.167

10.  Development of heart and respiratory rate percentile curves for hospitalized children.

Authors:  Christopher P Bonafide; Patrick W Brady; Ron Keren; Patrick H Conway; Keith Marsolo; Carrie Daymont
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

View more
  2 in total

1.  Clinical utility of procalcitonin in bacterial infections in patients undergoing hematopoietic stem cell transplantation.

Authors:  Amit Bansal; Preethi Jeyaraman; S K Gupta; Nitin Dayal; Rahul Naithani
Journal:  Am J Blood Res       Date:  2020-12-15

2.  Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients-Results from a Prospective Study in Two Major Large European Cancer Centers.

Authors:  Stefan Schöning; Anke Barnbrock; Konrad Bochennek; Kathrin Gordon; Andreas H Groll; Thomas Lehrnbecher
Journal:  Antibiotics (Basel)       Date:  2022-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.